Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance.

导出 OA

翻译打印收藏纠错

第一作者： Tameka A,Bailey

第一单位： Eppley Institute for Research in Cancer and Allied Diseases, College of Medicine, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE, USA.

作者： Tameka A,Bailey ^[1] ; Haitao,Luan ; Robert J,Clubb ; Mayumi,Naramura ; Vimla,Band ; Srikumar M,Raja ; Hamid,Band

作者单位： Eppley Institute for Research in Cancer and Allied Diseases, College of Medicine, University of Nebraska Medical Center, 985950 Nebraska Medical Center Omaha, NE, USA. ^[1]

关键词 ErbB2 (Her2/Neu)mechanism resistance trastuzumab

DOI 10.4103/1477-3163.90442

PMID 22190870

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览53

Journal of carcinogenesis

2011年10卷

28页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance.

Journal of carcinogenesis

相似文献

Journal of carcinogenesis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance.

Journal of carcinogenesis

相似文献

Journal of carcinogenesis

相关期刊

检索历史清除